[{"id":"0ece5d66-5019-42a5-84bf-ce2983ed70cd","acronym":"","url":"https://clinicaltrials.gov/study/NCT04973098","created_at":"2021-07-22T17:52:56.624Z","updated_at":"2024-07-02T16:36:21.347Z","phase":"Phase 1","brief_title":"Phase I Clinical Trial of CT0181 Cells in the Treatment of Hepatocellular Carcinoma","source_id_and_acronym":"NCT04973098","lead_sponsor":"Peking University","biomarkers":" GPC3","pipe":"","alterations":" ","tags":["GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CT0181"],"overall_status":"Recruiting","enrollment":" Enrollment 13","initiation":"Initiation: 08/05/2021","start_date":" 08/05/2021","primary_txt":" Primary completion: 08/01/2022","primary_completion_date":" 08/01/2022","study_txt":" Completion: 06/01/2023","study_completion_date":" 06/01/2023","last_update_posted":"2021-11-04"}]